Indiana Trade Group Raises Concerns With Medicare’s CED Fact Sheet
This article was originally published in The Gray Sheet
The Indiana Medical Device Manufacturers Council (IMDMC) is asking CMS to remain flexible with its deadlines for releasing a final coverage-with-evidence-development (CED) guidance
You may also be interested in...
CMS' coverage-with-evidence-development (CED) policy mainly will be used to generate data for FDA-approved products that are being used for a different indication, according to the agency
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.